Zolpidem Orodispersible
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zolpidem Orodispersible, covering 2020-07-27 to 2020-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder. [Phase 2, Phase 3]